Position in CLDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$24,105,977
+$17,281,134 QoQ
Shares Held
647,836
+201.1% QoQ
Ownership
0.825%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#34
of 252 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. CLDX ranks #4 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
515,343 | $29,956,888 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
845,118 | $29,908,726 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
419,773 | $25,337,498 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
This page
|
647,836 | $24,105,977 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
95,335 | $23,335,147 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
1,051,465 | $22,985,024 | |
| 7 | MRNA |
Moderna, Inc.
|
274,820 | $19,245,644 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
649,027 | $17,510,748 |
All Filings in CLDX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,105,977 | 647,836 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,824,843 | 215,159 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,684,684 | 98,847 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,683,934 | 103,747 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,682,637 | 180,965 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,424,785 | 133,597 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,636,595 | 104,337 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,868,872 | 54,983 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,798,474 | 75,614 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,806,808 | 43,050 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $393,030 | 9,910 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $793,401 | 28,830 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,339,556 | 39,480 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $850,423 | 23,636 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $369,619 | 8,293 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $647,457 | 23,033 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $508,061 | 18,845 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $476,329 | 13,985 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $277,628 | 7,185 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $440,288 | 8,155 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $192,369 | 10,980 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $668,388 | 45,070 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||